ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.35X leverage
Performance
- Low
- ₹1,464
- High
- ₹1,481
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,477
- Previous Close₹1,477
- Volume32,928
- 50 DMA₹1,561.33
- 100 DMA₹1,586.20
- 200 DMA₹1,557.44
Investment Returns
- Over 1 Month -6.25%
- Over 3 Month -7.85%
- Over 6 Month -15.61%
- Over 1 Year + 15.32%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48.3
- PEG Ratio
- 2.5
- Market Cap Cr
- 20,077
- P/B Ratio
- 6.5
- Average True Range
- 39.37
- EPS
- 30.52
- Dividend Yield
- 0.5
- MACD Signal
- -18.26
- RSI
- 35.26
- MFI
- 28.21
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,473.90
-3.2
(-0.22%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,527.55
- 50 Day
- ₹1,561.33
- 100 Day
- ₹1,586.20
- 200 Day
- ₹1,557.44
Resistance and Support
1472.97
- R3 1,498.33
- R2 1,489.57
- R1 1,481.73
- S1 1,465.13
- S2 1,456.37
- S3 1,448.53
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-07 | Interim Dividend |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,473 As on 15 January, 2026 | 11:03
The Market Cap of Eris Lifesciences is ₹20077 Cr As on 15 January, 2026 | 11:03
The P/E ratio of Eris Lifesciences is 48.3 As on 15 January, 2026 | 11:03
The PB ratio of Eris Lifesciences is 6.5 As on 15 January, 2026 | 11:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.